Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
drug-abuse-risk-management
Press Release
Jun 21, 2018
Crossing the Blood-Brain Barrier - the Human Element of Abuse Potential Assessment, New Webinar Hosted by Xtalks
CNS drug developers have to focus on physical safety and efficacy first, especially when developing products for rare disorders or diagnoses that are often unresponsive to other therapies. Although these products rarely have notable CNS mediated side effects, they fall under the FDA's requirement for an abuse potential assessment because they cross the blood-brain barrier.
Read More
Press Release
Jun 18, 2018
Upcoming Xtalks Webinar: Crossing the Blood-Brain Barrier? FDA Requires an Abuse Potential Assessment
Read More
First
Prev
1
Next
Last
